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Lancaster, Lancaster, United Kingdom
Background: Maintaining nutritional status is a key component of care in people
with cystic ﬁbrosis. Low socioeconomic status has been linked with poor outcomes
in CF. We explored, for the ﬁrst time in a UK-wide cohort, longitudinal weight gain
and its relationship with socioeconomic status (SES).
Methods: We undertook a retrospective longitudinal cohort study of 4,346 people
with cystic ﬁbrosis aged less than 20 years (21,132 observations) in UK CF registry
between 1995 and 2006. Census based indices of multiple deprivation (IMD) from
the UK constituent counties were used as small area measures of SES. Piecewise
mixed model regression was used to estimate the effect of SES on weight-for-age
z-score (WFA).
Results: WFA was signiﬁcantly lower in the most deprived quintile at all time
points. The estimated WFA at birth (intercept) was −0.64 in the least deprived
quintile compared to −1.31 in the most deprived (mean difference 0.67, 95%CI
0.42−0.92). The population WFA increased up to age three by 0.2 per year, and
then declined subsequently by −0.033 per year. There was a signiﬁcantly steeper
improvement in WFA in the most deprived quintile in the ﬁrst 3 years (mean
difference per year 0.13, 95%CI 0.06−0.20), with no difference in the rate of
decline subsequently.
Conclusions: Social deprivation is associated with lower WFA in the UK cystic
ﬁbrosis population, but there is a period of increased weight gain in the ﬁrst three
years, highlighting the importance of early diagnosis and treatment.
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Question: Resent studies showed, that underweight in patients with cystic ﬁbro-
sis (CF) is correlated with decreased lung function. Further it was shown that gain
of weight resulted in a better lung function. We want to investigate the inﬂuence of
adiposity (BMI >90th percentile) on the long term changes in pulmonary function.
Methods: Using the data from the German CF-registry we focused on patients
whose weight exceed the 90th BMI-Percentile in 1999 and 2009. We matched
each of those patients with two patients of normal weight in the same years.
Normal weight was deﬁned as a BMI between the 25th and the 75th percentile.
Furthermore the controls were matched for age (+/−) one year, gender, lung function
(FEV1 +/− 7%) in 1999 and the same status for Pseudomonas aeruginosa (PSA)
in 1999 and 2009.
Results: We identiﬁed 28 obese patients (12 male, 16 female). The mean age (+SD)
in 1999 was 18.22+9.03 years. Lung function measurements were reported in 23
of those patients and 46 matched controls. Both groups showed the same trend
of their lung function. In both a decrease of <1% per year was registered. There
was a 8.2+19.5% decrease of FEV1 %predicted in the obese patients compared to
10.3+16.7% decrease of FEV1 %predicted in the controls.
Conclusion: Over a period of 10 years the comparison of the lung function in obese
patients compared to patients of normal weight showed no advantage for patients
with adiposity. There is no advantage for adiposity at least relating long term
changes in pulmonary function. Since there are known disadvantages of adiposity,
we conclude that patients with CF should aim for a normal weight between the
25th and the 75th percentile.
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Objectives: Chronic catabolic state in malnourished cystic ﬁbrosis (CF) patients
leads to lean body mass depletion that is poorly detected by routine nutritional
indicators. This study aimed to determine body composition changes in pediatric
CF patients using bioimpedance spectroscopy (BIS)-derived indices of adipose and
lean tissue mass compared to standard anthropometric evaluation.
Methods: 36 CF patients aged 5 to 18 years were enrolled in this cross-sectional
study. Anthropometric measurements [height-for-age, BMI and mid upper arm
circumference (MUAC)] were evaluated according to national reference data.
Body composition was assessed using a BIS device (Body Composition Monitor,
Fresenius). Adipose tissue index (ATI (kg/m2) = adipose tissue mass/height2) and
lean tissue index (LTI (kg/m2) = lean tissue mass/height2) were used as indices
of fat mass and lean mass respectively and were evaluated using manufacturer
provided reference ranges for children and adolescents. BMI, MUAC, ATI and LTI
percentile <10th were used as cutoff points deﬁning nutritional failure.
Conclusion: Mean z scores for height, BMI and MUAC were −0.61, −1.08 and
−1.31 respectively. BMIp values >10th were found in 57% males and 73% females.
17% of males and 36% of females with BMIp >10th had LTIp< 10th (hidden
lean tissue mass depletion). In 22% of males with BMIp< 10th isolated fat mass
reduction was identiﬁed, all females with BMIp< 10th had lean tissue depletion.
Lean tissue loss was undetectable by BMI in 22% of males and 50% of females
with LTIp< 10th.
Bioimpedance spectroscopy reveals lean tissue mass depletion undetected by BMI.
Hidden lean tissue loss seems to be more severe in females.
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Lung transplantation offers improved survival and quality of life for patients with
advanced cystic ﬁbrosis (CF) lung disease. The ISHLT guidelines for transplantation
lists BMI> 30 as a relative contraindication, yet there is no reference to low BMI.
At our centre patients are preferred to have a BMI> 17 prior to transplantation.
We reviewed BMI of our CF cohort undergoing transplantation, and its effect on
survival.
A retrospective case note and database review was conducted. BMI pre transplanta-
tion was recorded. Survival of those above and below the median BMI was analysed.
A recent paper from our centre demonstrated signiﬁcantly poorer survival in those
with Burkholderia cenocepacia to the extent that these candidates are no longer
accepted for transplantation. Therefore this cohort was excluded from analysis.
238 patients with CF have been transplanted since start of programme. 12 were
colonised with Burkholderia cenocepacia and excluded from analysis. Median BMI
was 18.8 (range 12−27). 15 recipients had no record of pre-transplantation BMI.
Those with a BMI below the median had a 30 day survival of 92%, 1 year 79%,
5 year 59% and 10 year 46%. Those above the median BMI had a 30 day survival of
96%, 1 year 91%, 5 year 71% and 10 year 62%. Overall survival was signiﬁcantly
better in those with a BMI above the median (p = 0.018).
At our centre, those undergoing lung transplantation for advanced CF lung disease
have signiﬁcantly poorer survival if their BMI is below the median of 18.8.
Multivariate analysis has not been performed, yet this data provides some evidence
that lower BMI is a prognostic indicator of reduced survival for these patients.
